FDA Approval Activities for this Drug…

Patanol (olopatadine hydrochloride ophthalmic solution), 0.1%, Alcon, NDA 20-688/S-016 4/17/03 Patanol (olopatadine ophthalmic solution), 0.1%, Alcon NDA 20-688/S12 3/20/00 3/21/00 Patanol Indications: Treatment of signs and symptoms of allergic conjunctivitis. | Olopatadine hydrochloride ophthalmic solution, Alcon, Inc., Approval

For the latest approval information, please locate this drug using this index.